🇺🇸 FDA

Company profile · Sponsor

Tianjin

Tianjin Hemay Pharmaceutical Co., Ltd

C210D78 · NMPA pharma CN
Pipeline
1
Drugs
0
Patents
0

Quick answer

Tianjin (C210D78) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

Company facts

Ticker C210D78
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (1)

Search pipeline →

  1. Hemay020

    Tianjin

    Neoplasms，Non-Small Cell Lung Cancer

    phase 1 small molecule terminated

    1 trial

Frequently asked questions

What is Tianjin?

Tianjin (C210D78) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

What pipeline programs does Tianjin sponsor?

We track 1 ClinicalTrials.gov-linked program for Tianjin, including Hemay020. Open each program for phase, modality, NCT IDs, and indication details.

Where does Tianjin company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.